Current Affairs
Daily Bits

DCGI approves Covaxin for kids in 2-18 age group

  • Posted By
    10Pointer
  • Categories
    Science & Technology
  • Published
    13th Oct, 2021

In a significant development, Bharat Biotech's COVID-19 vaccine, Covaxin, got DGCI's approval for usage on kids aged 2-18. 

Context

In a significant development, Bharat Biotech's COVID-19 vaccine, Covaxin, got DGCI's approval for usage on kids aged 2-18. 

Key-points

  • Covaxin, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
  • The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
  • The vaccine is developed using Whole-Virion Inactivated Vero Cellderived platform technology.
    • Inactivated vaccines do not replicate and are therefore unlikely to revert and cause pathological effects.
      • They contain dead virus, incapable of infecting people but still able to instruct the immune system to mount a defensive reaction against an infection.
    • The World Health Organization (WHO) is yet to grant emergency use authorisation to Covaxin.

Bharat Biotech based in Hyderabad

  • Bharat Biotech Indian biotechnology is based in Hyderabad,
  • Bharat Biotech International Limited specializes in drug discovery, drug development, vaccine production, bio-therapeutics, pharmaceuticals, and health care products.

Verifying, please be patient.

X